Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Selling, general, and administrative expenses
3Y CAGR
+44.4%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
3x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $16.54M | +32.6% |
| 2024 | $12.47M | +97.3% |
| 2023 | $6.32M | +15.0% |
| 2022 | $5.50M | -12.6% |
| 2021 | $6.29M | - |